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Letter to the EditorMortality  of children  following  a  diagnosis  of HIV  infection
after  2000 compared to those born ≤ 2000 was marginally
reduced (HR = 0.42; p value = 0.054) (Fig. 1).
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Globally HIV is the seventh leading cause of death among
infants  and children from 1 to 59 months of age. An estimated
230,000  children died from AIDS-related illnesses in 2011.1
Brazil has a mixed HIV epidemic, and pediatric cases are more
common  in the nine provinces of the north and northeast and
survival  after AIDS diagnosis is lower than in the rest of the
country.2 The probability of survival at 60 months rose from
25%  before 1988 to 88% in 2001–2002.3
To identify if the general improvement in survival was also
extended  to children in the Northeast region, we studied mor-
tality  in children with HIV infection in the state of Sergipe.
A  historical cohort of 101 HIV-infected children diagnosed
from  1993 to 2011 was  identiﬁed laboratory and surveillance
databases, as well as from ambulatory medical records of the
University  Hospital and reference center. The starting date
corresponds to the diagnosis of the ﬁrst case of HIV in infants
reported  in Sergipe.
We  examined two outcome variables. The ﬁrst was  death,
and  the second was  survival from birth, as a proxy for survival
time  from HIV infection. We  chose not to examine survival
from  AIDS diagnosis to death because a substantial proportion
of  cases were  diagnosed close to death or post-mortem. For
children  who  had not died, the date of censoring was  the last
record  time of contact with the medical center. We used logis-
tic  regression analysis and a purposeful covariate selection
process  to identify predictors associated with death. Using
the  Wald, we  further explored the variables in a multivari-
ate  analysis using stepwise modeling techniques. We  removed
covariates  if statistical signiﬁcance was  lost (p-value < 0.10)
and  the variable was  found not to be a cofounder through its
effect  on other parameters in the models. Additionally, we  per-
formed  a Kaplan–Meier survival analysis from birth, censoring
data  at death or last known day of follow-up. We  conducted all
analyses  with the R 2.15.3 for Windows (R Development Core
Team,  Vienna, Austria). At the time we interviewed parents to
complete data collection, we obtained informed consent. The
study  was  approved by local ethical committee.
Between 1990 and 2011, 101 infants and children were diag-
nosed  with HIV infection in Sergipe. Sixty-two (61%) were
female,  and the median age at HIV diagnosis was  3.0 years
(interquartile range [IQR], 1.5–5.6 years). Twenty-one (21%)
died.  The median age at death was  4.3 years (IQR, 1.5–5.6years).  Nine (43%) children who had died were  diagnosed with
AIDS  in their ﬁnal hospital admission or post mortem, and four
(19%)  were  diagnosed within four weeks of death. The median
survival  time from birth was 52 months (IQR, 18–88 months).
Clinical factors associated with death in univariate analysis
were  the presence of clinical AIDS symptoms, CDC  stage C
disease,  being born in 2000 or earlier and having a history of
hospital  admission. Being treated with triple-drug combina-
tion  ART was  protective. In a subset of patients for whom
full  records were  available, antiretroviral prophylaxis, mode
of  delivery and avoidance of breastfeeding were not associ-
ated  with death. In multivariate analysis, after adjusting for
current  treatment, the risk of death was 57% lower for chil-
dren  born after 2000 compared to those born ≤ 2000 (adjusted
relative  risk [aRR] 0.43, p < 0.05). Similarly, after adjusting for
birth  cohort, the risk of death decreased by 44% for every
incremental advancement in treatment from no treatment
to  monotherapy to dual therapy to triple therapy (aRR 0.56,
p  < 0.01). Lastly, the hazard ratio for death for children bornMonths
Fig. 1 – Survival by birth cohort, children with HIV
infection, Sergipe, Brazil, 1993–2011.
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We  found that the risk of death decreased over time in chil-
ren  with HIV infection in the northeastern Brazilian state
f  Sergipe, consistently with trends seen in other settings
round  the world4,5 and in Brazil.3 Not surprisingly, sicker chil-
ren,  those with later stage disease, clinical AIDS and with
istories  of hospital admission, and those who had been inad-
quately  treated were more  likely to have died, as has been
een  elsewhere.4,5 As HIV diagnosis becomes more  timely in
razil  with near universal screening of pregnant women  and
arly  HIV antigen testing, we  expect the proportion of children
ately  diagnosed to decrease and survival to rise.
We  conclude that in this population-based registry study
he  risk of death is lower in children born after 2000 and is
onsistent  with increasing survival that has been observed
lsewhere in Brazil.3 As diagnosis of HIV becomes more  timely
ith  virologic testing of younger children, survival from HIV
iagnosis  to death will be an important indicator to monitor
he  quality of care in this population.
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